#olmesartan medoxomil

[unayang]

Olmesartan medoxomil 144689-63-4

[verdantpharma]

Olmesartan medoxomil manufacturers in India

Olmesartan Medoxomil Manufacturers in India: A Growing Market for Cardiovascular Health

Olmesartan Medoxomil, an angiotensin II receptor antagonist (ARB), is a widely prescribed medication for the treatment of hypertension (high blood pressure) and chronic kidney disease. Its growing demand has spurred the development of an extensive manufacturing industry in India, which is one of the largest suppliers of pharmaceutical products worldwide. Indian manufacturers play a pivotal role in the production and export of Olmesartan Medoxomil, meeting the needs of both domestic and international markets.

The Importance of Olmesartan Medoxomil

By preventing this action, the drug helps to relax and dilate blood vessels, thereby lowering blood pressure. This makes it an essential treatment for individuals with hypertension, and it is often used alone or in combination with other medications. Its effectiveness in reducing the risk of stroke, heart attack, and kidney damage due to high blood pressure has made it a crucial part of many patients' treatment regimens.

The Indian Pharmaceutical Industry: A Global Powerhouse

India is one of the largest pharmaceutical markets globally, with the industry contributing significantly to the global supply of generic drugs. The country is often referred to as the "pharmacy of the world" because of its capacity to produce high-quality medications at competitive prices. With a robust infrastructure, skilled workforce, and compliance with international quality standards, India has become a key player in the manufacturing and export of pharmaceutical products, including Olmesartan Medoxomil.

Manufacturing Capabilities in India

Indian manufacturers of Olmesartan Medoxomil are known for their advanced production technologies, cost-effectiveness, and commitment to adhering to global regulatory standards. These manufacturers focus on producing high-quality active pharmaceutical ingredients (APIs) and finished formulations of Olmesartan Medoxomil.

1. Active Pharmaceutical Ingredients (APIs) Production:

The production of Olmesartan Medoxomil APIs is a complex and highly regulated process. Indian manufacturers often produce the active ingredient in-house or source it from specialized API producers. These APIs undergo strict quality control measures to ensure consistency, purity, and potency. The manufacturing process requires compliance with Good Manufacturing Practices (GMP) and other international standards such as the United States Pharmacopeia (USP) and European Pharmacopeia (EP).

2. Formulation and Packaging:

Once the active ingredient is produced, Indian manufacturers move to the next phase of producing the finished dosage form of Olmesartan Medoxomil, which may be available in tablet, oral suspension, or combination formulations. Packaging is another important aspect of the production process, as it ensures the medication is stored and transported safely while maintaining its efficacy.

3. Regulatory Compliance and Quality Assurance:

India has a stringent regulatory framework that governs pharmaceutical manufacturing. Manufacturers of Olmesartan Medoxomil must comply with guidelines set by the Central Drugs Standard Control Organization (CDSCO), which is the national regulatory authority. Additionally, many Indian manufacturers also obtain approvals from major global regulatory bodies such as the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and the World Health Organization (WHO).

The compliance with these regulations helps Indian manufacturers maintain the trust and confidence of international markets, making them attractive partners for global pharmaceutical companies.

Key Benefits of Olmesartan Medoxomil Manufacturing in India

1. Cost Efficiency:

Indian manufacturers can produce Olmesartan Medoxomil at a significantly lower cost compared to their counterparts in Western countries. This is primarily due to the lower labor costs, efficient production processes, and economies of scale available in India. These cost advantages allow manufacturers to offer competitive pricing on the global market, making the drug more accessible to patients worldwide.

2. Strong Export Market:

India’s pharmaceutical exports are booming, with a substantial portion directed toward emerging markets, as well as developed countries like the United States and European nations. As the demand for Olmesartan Medoxomil grows, Indian manufacturers are able to meet this demand not only in their domestic market but also by exporting to a variety of regions, ensuring that patients around the world have access to affordable and effective treatment.

3. Commitment to Quality:

Indian pharmaceutical manufacturers have built a reputation for high-quality production. Many Indian pharmaceutical companies are accredited by international regulatory bodies, ensuring that Olmesartan Medoxomil produced in India meets global quality standards. These certifications and audits are crucial in establishing the trust of healthcare professionals and consumers.

4. Research and Development:

The pharmaceutical industry in India is known for its strong emphasis on research and development (R&D). Manufacturers of Olmesartan Medoxomil are continuously looking for ways to improve the formulation, enhance patient compliance, and explore new delivery methods. This focus on R&D also drives innovation and the development of combination therapies, further expanding the potential therapeutic uses of the drug.

The Future of Olmesartan Medoxomil Manufacturing in India

The demand for Olmesartan Medoxomil is expected to continue rising, driven by the global increase in hypertension and related cardiovascular diseases. As awareness of the benefits of blood pressure management increases, more patients will seek access to effective treatment options like Olmesartan Medoxomil. India’s pharmaceutical industry is well-positioned to meet this demand with its established manufacturing infrastructure, robust regulatory framework, and global reach.

Moreover, as global healthcare markets continue to prioritize affordable and accessible medications, Indian manufacturers will likely play a central role in supplying Olmesartan Medoxomil to various regions. The combination of cost efficiency, advanced manufacturing techniques, and a focus on quality ensures that Indian-made Olmesartan Medoxomil will remain a key player in the treatment of hypertension worldwide.

Conclusion

The manufacture of Olmesartan Medoxomil in India represents a success story in the country’s pharmaceutical sector. With its competitive pricing, adherence to global quality standards, and ability to meet growing global demand, India is positioned as a leader in the production and export of this crucial cardiovascular medication. As hypertension continues to be a global health concern, India’s role in the supply of Olmesartan Medoxomil will remain vital in helping improve patient outcomes worldwide.

URL: For more information, visit Verdant Pharma : Olmesartan Medoxomil Manufacturers in India

[qndq]

Olmesartan Medoxomil 20mg & Hydrochlorothiazide 12.5 mg Tablets Manufacturers in India

Olmesartan Medoxomil 20 mg & Hydrochlorothiazide 12.5 mg Tablets are classified as "anti-hypertensive," a class of medication used to reduce high blood pressure (hypertension) by flushing out surplus fluid (electrolytes) in the body. A persistent condition known as high blood pressure causes strong blood pressure against the artery walls. As one of the top Olmesartan Medoxomil 20 mg & Hydrochlorothiazide 12.5 mg Tablets Manufacturers in India, we at QndQ Cardia produce and offer these medications in various strengths and packaging.

[cvrlifecsience]

Leading olmesartan medoxomil manufacturer

The pharmaceutical company behind Olmesartan Medoxomil has played a pivotal role in revolutionizing cardiovascular care. Renowned for its commitment to research, development, and patient well-being, this manufacturer has consistently demonstrated excellence in producing high-quality medications that meet the evolving needs of the global population.

Olmesartan Medoxomil: A Brief Overview:

Olmesartan Medoxomil belongs to a class of medications known as angiotensin II receptor blockers (ARBs). It works by blocking the action of certain natural substances that tighten blood vessels, allowing for smoother blood flow and reduced blood pressure. Widely prescribed by healthcare professionals, Olmesartan Medoxomil has become synonymous with effective hypertension management and has improved the quality of life for countless individuals.

Quality Assurance and Regulatory Compliance:

The manufacturer of Olmesartan Medoxomil places a strong emphasis on quality assurance and compliance with stringent regulatory standards. Rigorous testing protocols and state-of-the-art manufacturing facilities ensure that each batch of medication meets the highest quality benchmarks. This commitment to excellence not only reflects the manufacturer's dedication to patient safety but also instills confidence in healthcare professionals and patients alike.

Research and Development:

The journey from molecule discovery to a widely prescribed medication involves years of dedicated research and development. The manufacturer of Olmesartan Medoxomil invests heavily in scientific exploration, seeking to improve existing formulations and explore new avenues in cardiovascular medicine. This commitment to innovation positions the company as a leader in the pharmaceutical industry, driving advancements that contribute to the overall well-being of society.

Patient-Centric Approach:

Beyond the manufacturing process, the company recognizes the importance of a patient-centric approach. Education and support programs are often established to help patients understand the importance of medication adherence and lifestyle modifications in managing hypertension effectively. By fostering a holistic approach to patient care, the manufacturer aims to empower individuals to take control of their health and lead fulfilling lives.

Conclusion:

In conclusion, the manufacturer behind Olmesartan Medoxomil stands as a paragon of pharmaceutical excellence, spearheading advancements in cardiovascular health. Through unwavering commitment to quality, research, and patient well-being, this company has earned its place as a trusted provider of life-changing medications. As we celebrate the strides made in hypertension management, it is essential to recognize and appreciate the contributions of the manufacturer that continues to shape the future of cardiovascular medicine.

[beaverstrack]

What is the intermediate in olmesartan?

The intermediate in the synthesis of olmesartan, a medication used to treat high blood pressure, is called 2,3-dihydro-2,4-dioxo-1H-1,2,4-benzothiadiazine-7-carboxylic acid. This intermediate is generated during the chemical synthesis of olmesartan medoxomil, which is the prodrug form of olmesartan. The medoxomil ester is subsequently converted to olmesartan in the body after oral administration.

Verdant Life Sciences is proud to be recognised as one of the leading olmesartan intermediate manufacturers in the industry. Founded in 2008 by a team of highly enterprising professionals, we have set our sights on redefining the industry and prioritising the health of patients over everything else. 

Visit : OLMESARTAN INTERMEDIATE MANUFACTURERS to knowmore !

[verdantlifescience]

Olm

Introduction

Olmesartan medoxomil is a medication commonly prescribed for the treatment of high blood pressure. It belongs to a class of drugs known as angiotensin II receptor blockers (ARBs). In this article, we will explore the various aspects of olmesartan medoxomil, including its mechanism of action, benefits, side effects, dosage, and more.

What is Olmesartan Medoxomil?

Olmesartan medoxomil is the active ingredient in medications like Benicar and Olmetec. It is primarily used to manage hypertension or high blood pressure. Olmesartan medoxomil works by blocking the action of angiotensin II, a hormone that constricts blood vessels, thereby causing blood pressure to rise. By inhibiting the effects of angiotensin II, olmesartan medoxomil helps relax blood vessels, reducing blood pressure and improving blood flow.

How Does Olmesartan Medoxomil Work?

Olmesartan medoxomil works by selectively binding to the angiotensin II receptor in blood vessels, preventing angiotensin II from exerting its vasoconstrictive effects. By doing so, it promotes vasodilation and reduces peripheral resistance, allowing blood to flow more easily. This mechanism helps lower blood pressure and can effectively manage hypertension.

Benefits of Olmesartan Medoxomil

Effective blood pressure control: Olmesartan medoxomil has been shown to effectively lower blood pressure levels, helping individuals maintain healthy blood pressure ranges.

Kidney protection: This medication may provide additional benefits by protecting the kidneys, especially in individuals with diabetes or kidney problems.

Heart health support: By reducing blood pressure, olmesartan medoxomil can help lower the risk of cardiovascular diseases, such as heart attacks and strokes.

Improved blood flow: The relaxation of blood vessels promoted by olmesartan medoxomil enhances blood flow throughout the body, ensuring oxygen and nutrients reach tissues and organs adequately.

Side Effects of Olmesartan Medoxomil

While olmesartan medoxomil is generally well-tolerated, some individuals may experience side effects. Common side effects include dizziness, headache, diarrhea, nausea, and fatigue. In rare cases, more severe side effects such as allergic reactions, chest pain, or swelling may occur. It is important to consult a healthcare professional if any concerning symptoms arise.

Dosage and Administration

The dosage of olmesartan medoxomil may vary depending on the individual's condition and response to treatment. It is typically taken orally once a day, with or without food. It is crucial to follow the prescribed dosage and directions provided by the healthcare provider. Regular blood pressure monitoring is also essential to evaluate the effectiveness of the medication.

Precautions and Interactions

Before taking olmesartan medoxomil, it is important to inform the healthcare provider about any existing medical conditions or ongoing medications. This medication may not be suitable for individuals with a history of angioedema or those who are pregnant or planning to become pregnant.

[siglerprescriptiondrugcards]

Olmesartan Medoxomil

Brand Name: Benicar

Generic Available

Common Dosage Forms:

Tablets: 5 mg, 20 mg, 40 mg

FDA Indications/Dosages:

For the treatment of hypertension: The usual recommended starting dose is 20 mg once daily when used as monotherapy in patients who are not volume-depleted. For patients requiring further reduction in blood pressure after 2 weeks of therapy, the dose may be increased to 40 mg once daily. A lower starting dose should be considered in patients with possible depletion of intravascular volume (e.g., patients treated with diuretics, particularly with impaired renal function). No initial dosage adjustment is recommended for elderly patients, for patients with moderate to marked renal impairment (CrCl <40 mL/min), or with moderate to marked hepatic dysfunction.

Monitor: CrCl, BP, K

Pharmacology/Pharmacokinetics: Angiotensin II is a potent vasoconstrictor, the primary vasoactive hormone of the renin-angiotensin system and an important component in the pathophysiology of hypertension. It also stimulates aldosterone secretion by the adrenal cortex. Olmesartan medoxomil is a prodrug which is hydrolyzed to Olmesartan during absorption from the gastrointestinal tract. Olmesartan blocks the vasoconstrictor and aldosterone-secreting effects of angiotensin II by selectively blocking the binding of angiotensin II to the AT1 receptor found in many tissues. Olmesartan does not inhibit ACE, nor does it bind to or block other hormone receptors or ion channels known to be important in cardiovascular regulation. Once absorbed, there is virtually no further metabolism of Olmesartan. The terminal half-life of Olmesartan is about 13 hours. Mean peak concentrations are reached in 1-2 hours. It is highly bound (99%) to plasma proteins.

Drug Interactions: NSAIDs, including COX-2 inhibitors, may decrease effects and increase risk of renal function deterioration. Increased adverse effects may occur when used with other renin-angiotensin system blockers or aliskiren. Colesevelam HCl decreases plasma levels.

Contraindications/Precautions: Contraindicated with aliskiren. DO NOT USE DURING PREGNANCY. Do not use in nursing mothers. Drugs that act directly on the renin-angiotensin system can cause fatal and neonatal morbidity and death when administered to pregnant women. In patients who are intravascularly volume-depleted, symptomatic hypotension may occur after initiation of therapy. A lower dose should be considered for these patients. Pregnancy Category D.

Adverse Effects: The most common adverse effect seen during therapy is dizziness (3%). Less common adverse effects include back pain, bronchitis, creatine phosphokinase increased, diarrhea, headache, hematuria, hyperglycemia, hypertriglyceridemia, influenza-like symptoms, pharyngitis, rhinitis, and sinusitis.

Patient Consultation:

May be administered with or without food.

May cause dizziness. Use care when operating machinery.

If pregnancy is directed, discontinue use as soon as possible.

Store in a cool, dry place away from sunlight and children.

Contact a physician if the above side effects are severe or persistent.

[chemanalysta]

Olmesartan Medoxomil Price showcased a stable trend in the North American region, followed by market disruptions. Supply disruptions from the APAC region amid high transportation costs resulted in a shortage of inventories, impacting the price dynamics of Olmesartan Medoxomil in the USA. Hampered production activities due to the COVID-19 lockdown curbs in China caused disruptions in the supply chain between USA and China. Due to the shortage of containers, domestic downstream customers had trouble getting their hands on supplies. Stability in the downstream demand from the pharmaceutical industry and high inflation pressure on the enterprises kept costs steady in the second quarter of 2022. Towards the end of Q2 of 2022, Olmesartan Medoxomil prices were assessed at USD 739506/MT for CFR New York in June 2022.

[smithpharma-blog]

Olmesartan Medoxomil - In House Impurity

Catalogue Number: PA 15 26510 Chemical Name: cis-4,5-Dichloro-4,5-dimethyl-1,3-dioxolan-2-one CAS Number: 129482-56-0 Category: chiral standards,heterocycles,intermediates Synonyms: (Z)-4,5-Dichloro-4,5-dimethyl-1,3-dioxolan-2-one; Molecular Form: C5H6Cl2O3 Mol. Weight: 185.00

For more details visit here.

[aolisenchem]

API

API Active Pharmaceutical Ingredients can be produced from all kinds of Pharmaceutical Intermediates.

 Pharmaceutical Intermediates are the raw materials of API active principle ingredient. API means substance or mixture of substances intended to be used in the output of api products in drugs and pharmacy industry or sector. The pharma api drug manufacturing unit is an active ingredient of pharmaceuticals. Such api and intermediates have pharmacological activity or effects in the treatment, diagnosis, symptom relief, treatment or prevention of diseases, or can affect the function or structure of the body. Only when APIs pharmacy or medicines are produced into pharmaceutical preparations, can be become medicines for clinical applications.

 We often do the global active pharmaceutical ingredients market research so as to gain more consumers and promise to generate better pharmaceutical active bulk drug substance compounds and api unit active ingredients and formulation in pharmaceutical products. As a professional and great active pharmaceutical ingredients supplier, we are dedicated to exploring api active pharmaceutical ingredient industry and api pharma tech field. we focus on the medicine api in pharmaceutical manufacturing as well as the api and intermediates in drug development.

 We make stability testing and validation of active pharmaceutical ingredients and finished pharmaceutical intermediate chemical products all the time and accumulate experience from examples of active pharmaceutical ingredients to ensure the quality of our products. Besides that, we also keep exploring and expanding the highly potent active pharmaceutical ingredients meaning and market as well as the api atypical active pharmaceutical ingredient manufacturing meanings in pharma industry. The attempt of exploring the api drugs meaning in pharma stands for that we want to product better goods to benefit the humankind. We have an abundant pharmaceutical api database to deal with more problems and our advanced active pharmaceutical ingredients list accords with the fda standard. We have plenty of top selling and most common highly active pharmaceutical ingredients, detailed information can be found in the specific website of products.

 As one of the professional active pharmaceutical ingredient manufacturers, we have various types of active pharmaceutical ingredients. If you want to get active pharmaceutical ingredients price list or buy active pharmaceutical ingredients, please contact with us.

 Other pharma api news and ppt can be found in the BLOG website.

 Chemical CAS

CAS started with 1:

 184475-35-2

183319-69-9

144689-63-4

123447-62-1

138530-94-6

CAS started with 2:

 274901-16-5

220127-57-1

204255-11-8

CAS started with 3:

 379270-37-8

CAS started with 4:

 CAS started with 5:

 CAS started with 6:

 CAS started with 7:

 CAS started with 8:

 863127-77-9

CAS started with 9:

 Popular API

Erlotinib hydrochloride CAS#183319-69-9

Gefitinib CAS#184475-35-2

Prulifloxacin CAS#123447-62-1

Olmesartan medoxomil CAS#144689-63-4

R-(+)-Lansoprazole CAS#138530-94-6

Imatinib mesylate CAS#220127-57-1

Vildagliptin CAS#274901-16-5

Oseltamivir phosphate CAS#204255-11-8

Tenofovir alafenamide CAS#379270-37-8

Dasatinib monohydrate CAS#863127-77-9

 https://www.aolisenchem.com/active-pharmaceutical-ingredients/

[qndq]

Leading the way in cardiovascular health solutions is QndQ Cardia, reputable Olmesartan Medoxomil Tablets Manufacturers in India. We offer hope to people looking for effective hypertension therapy through cutting-edge research, rigorous manufacturing procedures, and extensive patient assistance. For more details, call us at 9816857058 or visit our website

[edrugonline]

sevikar medication Uses, Dosage, Side Effects, Precautions & Warnings

sevikar medication Uses, Dosage, Side Effects, Precautions & Warnings

Generic  drug of the Therapeutic class: Cardiology and angiology Active ingredients: Olmesartan medoxomil , Amlodipine 

what is Sevikar ?

SEVIKAR is used to treat high blood pressure (hypertension) in patients whose blood pressure is not adequately controlled with either olmesartan medoxomil or amlodipine, each given alone.

PRESENTATION (S) AVAILABLE FOR SEVIKAR 20 MG / 5 MG

3 presentations are…

[pharmaffiliatesanalytics]

CAS No : 116857-05-7 | Product Name : trans-4,5-Dichloro-4,5-dimethyl-1,3-dioxolan-2-one | Pharmaffiliates

Buy highly pure trans-4,5-Dichloro-4,5-dimethyl-1,3-dioxolan-2-one, CAS No : 116857-05-7, Mol.Formula : C5H6Cl2O3, Mol.Weight : 185.01 from Pharmaffiliates. Login as registered user for prices, availability and discounts.